Neuronetics, Inc. (NASDAQ:STIM) Q1 2024 Earnings Call Transcript
Neuronetics, Inc. beats earnings expectations. Reported EPS is $-0.26713, expectations were $-0.33.
Neuronetics Inc. (STIM)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Archon Capital Management Constantinos J. Christofilis | 2,537,097 | $12,076,582 | 4.16% | |
| 2. | Cannell Capital J. Carlo Cannell | 2,463,256 | $11,725,099 | -12% | 2.51% |
| 3. | Divisadero Street Capital William Zolezzi | 1,539,447 | $7,327,768 | 1.71% | |
| 4. | Balyasny Asset Management Dmitry Balyasny | 1,169,505 | $5,566,844 | -18% | 0% |
| 5. | Kent Lake Capital Benjamin Natter | 1,021,151 | $4,860,679 | -9% | 2.12% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.81 | 28,500 | Director | 162,848 | 2023-08-10 | Filing | |
| $2.89 | 7,644 | Large Shareholder | 3,127,819 | 2023-03-17 | Filing | |
| $2.90 | 52,072 | Large Shareholder | 3,120,175 | 2023-03-16 | Filing | |
| $2.97 | 136,520 | Large Shareholder | 3,068,103 | 2023-03-13 | Filing | |
| $3.37 | 1,130 | Large Shareholder | 3,463,846 | 2022-06-17 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.94 | 6,026 | 389,333 | 2024-02-29 | Filing | ||
| $3.16 | 22,377 | 395,359 | 2024-02-28 | Filing | ||
| $3.16 | 3,985 | 483,776 | 2024-02-28 | Filing | ||
| $3.33 | 21,272 | 487,761 | 2024-02-27 | Filing | ||
| $3.30 | 20,292 | 1,372,278 | 2024-02-26 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,353,144 | $3,924,118 | 0% | |
| 2. | 1,126,484 | $3,266,804 | 0.02% | |
| 3. | 470,683 | $1,364,981 | 0.52% | |
| 4. | 380,129 | $1,102,374 | 0% | |
| 5. | 265,604 | $770,441 | 0% |
News See All
Neuronetics, Inc. (NASDAQ:STIM) Q4 2023 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Welcome to the Neuronetics Report Fourth Quarter 2023 Financial and Operating Results.
Neuronetics, Inc. (NASDAQ:STIM) Q3 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Neuronetics Third Quarter 2023 Conference Call.
Neuronetics, Inc. (NASDAQ:STIM) Q2 2023 Earnings Call Transcript
Operator: Thank you for standing by, welcome to the Neuronetics Second Quarter 2023 Financial and Operating Results Conference Call. At this time al participants’ are in a listen-only mode.
Neuronetics, Inc. (NASDAQ:STIM) Q1 2023 Earnings Call Transcript
Operator: Thank you for standing by, and welcome to the Neuronetics First Quarter 2023 Financial and Operating Results. [Operator Instructions] As a reminder, today's program is being recorded.
Neuronetics, Inc. (NASDAQ:STIM) Q4 2022 Earnings Call Transcript
Operator: Good day and welcome to the Neuronetics Fourth Quarter and Full-Year 2022 Conference Call. At this time, all participants are in listen-only mode.
Neuronetics, Inc. (NASDAQ:STIM) Q3 2022 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the Neuronetics Report Third Quarter 2022 Financial and Operating Results Conference Call.
10 Micro-Cap Stocks to Buy According to Hedge Funds
In this article, we will discuss 10 micro-cap stocks to buy according to hedge funds.
Hedge Funds Have Never Been This Bullish On Neuronetics, Inc. (STIM)
As we already know from media reports and hedge fund investor letters, hedge funds delivered their best returns in a decade.
Is STIM A Good Stock To Buy Now?
Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great stock picking abilities...
Billionaire Hedge Funds
